back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-09-27 16:07 Tx date 2024-09-26 |
$MDNA
Medicenna Therapeutics Corp. |
Geltosky, John Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
301,346 | |
| Filed 2023-10-02 21:38 Tx date 2023-09-28 |
$MDNA
Medicenna Therapeutics Corp. |
Geltosky, John Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
201,346 | |
| Filed 2022-06-28 16:00 Tx date 2022-06-24 |
$MDNA
Medicenna Therapeutics Corp. |
Geltosky, John Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$85,000
+58,621 vol $1.45 each |
101,346 | |
| Filed 2021-09-24 16:15 Tx date 2021-09-23 |
$MDNA
Medicenna Therapeutics Corp. |
Geltosky, John Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,999
+27,070 vol $3.14 each |
42,725 | |
| Filed 2020-11-06 16:04 Tx date 2020-11-03 |
$MDNA
Medicenna Therapeutics Corp. |
Geltosky, John Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$79,997
+15,655 vol $5.11 each |
15,655 | |
| Filed 2020-11-06 16:03 Tx date 2020-09-30 |
$MDNA
Medicenna Therapeutics Corp. |
Geltosky, John Edward
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-28 17:44 Tx date 2019-06-27 |
$SPHS
Sophiris Bio Inc. |
Geltosky, John Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,564
+20,000 vol $0.78 each |
76,500 | |
| Filed 2019-06-24 17:54 Tx date 2019-06-16 |
$SPHS
Sophiris Bio Inc. |
Geltosky, John Edward
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-19,387.50
-8,250 vol $2.35 each |
56,500 | |
| Filed 2018-11-15 Tx date 2018-10-24 |
$SPHS
Sophiris Bio Inc. |
Geltosky, John Edward
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-16,500 vol |
64,750 | |
| Filed 2018-06-28 Tx date 2018-06-27 |
$SPHS
Sophiris Bio Inc. |
Geltosky, John Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$58,200
+20,000 vol $2.91 each |
81,250 | |
| Filed 2017-06-01 Tx date 2017-05-30 |
$SPHS
Sophiris Bio Inc. |
Geltosky, John Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$48,800
+20,000 vol $2.44 each |
61,250 | |
| Filed 2017-06-01 Tx date 2016-02-10 |
$SPHS
Sophiris Bio Inc. |
Geltosky, John Edward
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-20,666.88
-576 vol $35.88 each |
33,000 | |
| Filed 2016-05-31 Tx date 2016-05-27 |
$SPHS
Sophiris Bio Inc. |
Geltosky, John Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$8,167
+8,250 vol $0.99 each |
41,826 | |
| Filed 2015-05-28 Tx date 2015-05-27 |
$SPHS
Sophiris Bio Inc. |
Geltosky, John Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$8,910
+8,250 vol $1.08 each |
33,576 |